Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 12 1997, 3078-3081, Vol 35, No. 12
LE Welsh, TC Quinn and CA Gaydos
The cellular quality of the endocervical swab specimen used for the
detection of Chlamydia trachomatis may dramatically impact the sensitivity
of the diagnostic assay used. An evaluation of the adequacy of 319
endocervical swab specimens from women attending two inner-city sexually
transmitted disease and family planning clinics, as well as five high
school-based family planning clinics, was performed, and the resulting data
were compared with the diagnostic results obtained by both Amplicor PCR and
Microtrak direct fluorescent-antibody (DFA) staining. The swab from each
patient was rolled across the open circular area of a DFA slide and then
used to inoculate a transport tube for PCR (Roche), after which the swab
was discarded. The slides were stained and examined by epifluorescence
microscopy for the presence of C. trachomatis elementary bodies and for the
presence and number of cell types to determine specimen adequacy. Cellular
adequacy for a cervical swab specimen was defined as the presence of one or
more columnar epithelial or metaplastic epithelial cells or the presence of
more than 100 erythrocytes per high-power microscopic field. Of the 319
specimens read by DFA, 204 (63.9%) were determined to be adequate. There
were 34 (10.7%) positive specimens by DFA and/or PCR. Twenty-nine (9.1%)
specimens were positive by PCR, 20 (6.3%) specimens were DFA positive, and
15 (4.7%) were concordantly positive by both tests. The prevalence of
chlamydia among adequate specimens was 14.2% (29/204), compared to 4.3%
(5/115) for inadequate specimens (P < 0.0001). Variations in specimen
quality and the sensitivity of the diagnostic assay used have a significant
impact on determining the prevalence of C. trachomatis in a population.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Influence of endocervical specimen adequacy on PCR and direct fluorescent-antibody staining for detection of Chlamydia trachomatis infections [In Process Citation]
The Johns Hopkins University, Baltimore, Maryland 21205, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|